Skip to content
Disclosery

Paradigm Biocapital Advisors LP: JANX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on JANX, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 0 JANX shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -2,920,258 shares

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 2,920,258 shares
    Change vs previous 13F 0 shares

    2.11% of the 13F portfolio, value $71,371,106.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 2,920,258 shares
    Change vs previous 13F -409,651 shares

    2.88% of the 13F portfolio, value $67,457,960.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 3,329,909 shares
    Change vs previous 13F -186,077 shares

    4.14% of the 13F portfolio, value $89,907,543.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 3,515,986 shares
    Change vs previous 13F +1,115,412 shares

    6.55% of the 13F portfolio, value $188,245,890.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-09-30
    13F 2,400,574 shares
    Change vs previous 13F not available

    3.82% of the 13F portfolio, value $109,058,077.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).